[Benzodiazepine therapy: an evaluation].
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D019966:Substance-Related Disorders / Q000209:etiology
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines
Therapie mit Benzodiazepinen: eine Bilanz.